Banco Santander S.A. raised its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 2.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 102,952 shares of the financial services provider’s stock after acquiring an additional 2,442 shares during the quarter. Banco Santander S.A.’s holdings in CME Group were worth $28,114,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. West Family Investments Inc. raised its position in shares of CME Group by 1.2% during the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the period. Asset Dedication LLC raised its position in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC raised its position in shares of CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares during the period. Rehmann Capital Advisory Group raised its position in shares of CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 37 shares during the period. Finally, 1248 Management LLC raised its position in shares of CME Group by 26.8% during the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 38 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.
CME Group Stock Performance
NASDAQ:CME opened at $269.53 on Friday. The business’s 50-day moving average price is $284.79 and its two-hundred day moving average price is $288.07. CME Group Inc. has a twelve month low of $244.56 and a twelve month high of $329.16. The stock has a market cap of $97.67 billion, a P/E ratio of 23.00, a PEG ratio of 2.93 and a beta of 0.21. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is 44.37%.
Trending Headlines about CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME announced four new E-mini futures contracts tied to broad-market equity benchmarks, plus new Micro E-mini options on the S&P 500 and Nasdaq-100. These launches could attract more trading volume by giving investors additional, lower-cost ways to hedge and gain market exposure. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
- Positive Sentiment: The company also said it will expand 24/7 trading for WTI crude oil and gold, which could improve price discovery and make CME’s metals and energy products more attractive to global traders operating outside normal market hours. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
- Positive Sentiment: CME launched Nasdaq CME Crypto Index futures and is moving deeper into digital-asset derivatives, giving investors regulated exposure to major cryptocurrencies and potentially opening another growth avenue for the exchange. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
- Neutral Sentiment: Erste Group Bank slightly raised its FY2026 EPS estimate for CME, signaling stable earnings expectations rather than a major change in outlook. MarketBeat report on CME estimate update
- Negative Sentiment: Some commentary around the CFTC’s crypto oversight has raised concerns about regulatory pressure and market criticism, which could create uncertainty for CME’s expanding crypto-related products. CFTC’s Lone Chair Selig Expands Grip Over Crypto and Prediction Markets
Analyst Upgrades and Downgrades
CME has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft lowered their target price on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Jefferies Financial Group lowered their target price on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research report on Thursday, April 9th. JPMorgan Chase & Co. upped their target price on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research report on Thursday, April 16th. Raymond James Financial upped their target price on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. Finally, Morgan Stanley decreased their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $305.71.
Insider Activity
In other news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 44,044 shares of company stock valued at $13,297,507. Company insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
